Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
The trial enrolled only people with overweight or obesity and no obesity-related illnesses
Davies said weight loss of up to 5% can improve hyperglycemia and hypertension, 5% to 10% weight loss can prevent type 2 diabetes and improve polycystic ovary syndrome and dyslipidemia, 10% to 15% weight loss can lead to improvements in cardiovascular disease and 15% or greater weight loss may induce type 2 diabetes remission and lower risks for CV mortality and heart failure with preserved ejection fraction
Fortunately, testosterone replacement therapy may help reduce night sweats if low T is the underlying cause
An ideal candidate for Semaglutide GLP-1 weight loss therapy is an adult with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition
Drug class: Tirzepatide is a dual GIP receptor and GLP-1 receptor agonist
US$ 24.43
US$ 26.46
US$ 26.44
US$ 26.01
US$ 29.40
US$ 23.06
US$ 20.16
US$ 29.22
US$ 21.39
US$ 29.58
